APA (7th ed.) Citation

ML, B., S, J. d. B., K, B., T, C., HI, C., M, C., . . . Y, T. (2022). Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study. Calcified tissue international, 111(4), 409. https://doi.org/10.1007/s00223-022-01006-7

Chicago Style (17th ed.) Citation

ML, Brandi, et al. "Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study." Calcified Tissue International 111, no. 4 (2022): 409. https://doi.org/10.1007/s00223-022-01006-7.

MLA (9th ed.) Citation

ML, Brandi, et al. "Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study." Calcified Tissue International, vol. 111, no. 4, 2022, p. 409, https://doi.org/10.1007/s00223-022-01006-7.